Liberum Capital restated their buy rating on shares of Galliford Try (LON:GFRD) in a research report released on Wednesday morning, ThisIsMoney.Co.Uk reports.
Several other research analysts also recently commented on GFRD. Peel Hunt reiterated an under review rating on shares of Motif Bio in a report on Monday, July 15th. Numis Securities reiterated a hold rating and issued a GBX 1,618 ($21.14) price objective on shares of Close Brothers Group in a report on Wednesday, May 22nd. Finally, Canaccord Genuity reiterated a hold rating and issued a GBX 860 ($11.24) price objective on shares of Galliford Try in a report on Tuesday, May 21st. Three analysts have rated the stock with a hold rating and two have given a buy rating to the company. The stock presently has an average rating of Hold and an average price target of GBX 868 ($11.34).
GFRD opened at GBX 642 ($8.39) on Wednesday. The stock has a market capitalization of $712.83 million and a P/E ratio of 6.23. The business has a 50-day moving average of GBX 632.95. The company has a debt-to-equity ratio of 159.63, a quick ratio of 0.80 and a current ratio of 1.21. Galliford Try has a 12 month low of GBX 499.60 ($6.53) and a 12 month high of GBX 1,117 ($14.60).
Galliford Try Company Profile
Galliford Try plc operates as a housebuilding, regeneration, and construction primarily in the United Kingdom. The company operates through Linden Homes, Partnerships & Regeneration, Building, Infrastructure, and PPP Investments segments. The company develops and sells private and affordable homes under the Linden Homes brand name; and builds sustainable communities, as well as provides private housing for sale on regeneration-led sites.
Featured Article: What is a good dividend yield?
Receive News & Ratings for Galliford Try Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Galliford Try and related companies with MarketBeat.com's FREE daily email newsletter.